Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Brain+ launches Ayla – your CST Assistant into the UK dementia market

Copenhagen, Denmark, 2 October 2024 – Brain+ A/S (Nasdaq First North: BRAINP) Brain+ A/S (“Brain+” or “the Company”) recently obtained certification and regulatory registration of Ayla – your CST Assistant as a Medical Device Software in the United Kingdom (UK). Subsequently, the product has now been released for sale. Ayla – your CST Assistant is the only UK certified digital solution to offer scalable, high-quality delivery of Cognitive Stimulation Therapy (CST), which is the only non-pharmacological dementia therapy that is recommended in the UK national health guidelines. Release means

Listing prospectus for Kesko’s EUR 300 million green notes available

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE OR SUCH OTHER COUNTRIES OR OTHERWISE IN SUCH CIRCUMSTANCES IN WHICH THE OFFERING OF THE NOTES OR THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Kesko Corporation (“Kesko”) announced its decision to issue green notes of EUR 300 million on 25 September 2024 (the “Notes”). The Notes mature on 2 February 2030 and they carry annual interest of 3.500 percent. The issue price of the Notes is 99.317 percent. The

AcuCort granted extended SME status by the European Medicines Agency (EMA)

AcuCort AB has been granted extended SME (Small or Medium-sized Enterprise) status by the European Medicines Agency (EMA).“The announcement from the EMA ensures that registration fees are kept as low as possible, and we can take advantage of the advisory services and other benefits available to small companies within the EU,” says Jonas Jönmark, CEO of AcuCort. For further information: Jonas Jönmark, vd, AcuCort ABTel: +46 70 365 5400Email: jonas.jonmark@acucort.se About AcuCort AB (publ)AcuCort has developed and is commercializing Zeqmelit®, a new rapidly dissolving oral film

SyntheticMR Receives Regulatory Approval for SyMRI 15 in Switzerland

SyntheticMR AB, global leader in advanced quantitative imaging software, is pleased to announce that its SyMRI 15 solution has received regulatory clearance in Switzerland.This milestone enables the company to market and distribute SyMRI 15 across the Swiss healthcare sector, marking a significant stride in SyntheticMR's strategic growth within Europe. SyMRI 15 is a groundbreaking imaging solution that revolutionizes conventional magnetic resonance imaging (MRI) practices. Clinically validated through an extensive multi-center study involving several top-tier institutes in the United

Avantra To Receive Substantial Investment from Resurgens Technology Partners To Further Enhance Its Position As Industry Leading AIOps Platform for SAP Operations

London, UK – October 1, 2024 – Avantra, a European leader in software solutions for monitoring and automating SAP operations, is receiving an investment from Resurgens Technology Partners (“RTP”), a private equity firm focused on investing in North American and European software companies. This partnership positions Avantra to accelerate its growth, with RTP providing the resources and expertise to scale operations and further develop its cutting-edge automation platform for SAP.“As we continue to scale our business, this partnership felt like the natural next step for us,” said John

Image System's business area RemaSawco receives an order from Rödins Trä AB for SEK 2.1 million

Rödins Trä AB has ordered an upgrade of the Log sorting station at its sawmill in Svenstavik. The order value amounts to SEK 2.1 million. Costs for commissioning are added.Rödins Trä AB plans to modernize and upgrade its Log sorting station for timber and has ordered a new measuring frame of the type RS-LogScanner3D and the measuring and sorting system RS-715 from RemaSawco. The order also includes modification and adaptation of the existing operator chair of the RS-FlexCon type. The upgraded system is now also compatible with Biometria's new timber measuring system Viol 3. The price

poLight Enabled SEBI RT1000 Development Kits from Wooptix Now Shipping

HORTEN, Norway – 2 October, 2024 – poLight ASA (OSE:PLT) today announced that the Wooptix Phase Camera SEBI® RT1000 development kit is now shipping, targeting applications such as quantitative phase imaging, optical metrology, material inspection, laser measurement, and oncological research. The development kit features TLens®, delivering continuous focus video recording or full-focus imaging, without any of the deficiencies of competing technologies, such as optical instability, changing field of view, magnetic interference, or gravity impacts. The collaboration and design win was first

Nel ASA: Saipem presents solution for large-scale green hydrogen production, utilizing Nel’s technology

(October 2, 2024 - Oslo, Norway) Nel ASA’s (Nel, OSE:NEL) EPC partner Saipem unveils IVHY™ 100, a scalable and modular 100 MW green hydrogen solution leveraging Nel’s technology, advancing the decarbonization of hard-to-abate industries and renewable hydrogen production. The innovative renewable hydrogen generation solution has been designed and industrialized to be scalable, modular, and to facilitate the installation and commissioning of large-scale systems. IVHY™ 100 is powered by Nel’s alkaline electrolysers, which have been tested in the market for decades, demonstrating world-class

Aker BP ASA announces completion of Senior Notes Offering

Aker BP ASA (the “Company”) is pleased to announce that it has successfully completed its senior notes offering (the “Offering”) of (i) $750 million aggregate principal amount of 5.125% Senior Notes due 2034 (the “2034 Notes”) and (ii) $750 million aggregate principal amount of its 5.800% Senior Notes due 2054 (the “2054 Notes”) (the 2034 Notes and 2054 Notes are collectively referred to as the “Notes”). The Company intends to use the net proceeds of the Offering for general corporate purposes and to purchase for cash any and all of its outstanding (i) 3.000% Senior Notes due 2025 (the “

Immunovia completes analytical validation of its next-generation pancreatic cancer test

LUND (SWEDEN) – Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, today announces that the company has completed the analytical validation of its next-generation test designed to detect early-stage pancreatic cancer. The validation demonstrated excellent results across a comprehensive set of parameters, reinforcing the reliability and robustness of the test.  The biomarkers that make up Immunovia’s next-generation test demonstrated excellent performance in a series of experiments. These experiments evaluated over 23 key performance attributes of the next-

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 218 – 2 OCTOBER 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 171/24 and 173/24, respectively. Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Martin Badsted, Chief Financial Officer, tel.: +45 33 42 05 26, e-mail: mba@norden.com

OssDsign has appointed Stephen Anderson as Vice President of Marketing

OssDsign AB (publ.) today announced that the company has appointed Stephen Anderson as Vice President (VP) of Marketing and a member of the executive management team. The recruitment is a strategic step to increase the company’s presence in the U.S.Stephen Anderson has over 25 years of global experience in marketing, sales, and engineering in the medical device industry. He has held various senior roles, including Senior Vice President of Sales and Marketing at Sharp Fluidics, Vice President of Sales and Marketing at NeoSurgical, Senior Director of Marketing at Invuity, and Global Director

BioStock: PHI accelerates growth with record order

Phase Holographic Imaging recently received its most significant order from Altium, comprising 20 HoloMonitor systems and additional components. This milestone aligns with the positive growth trajectory since the start of the year. PHI is also approaching the final exercise day of their TO 4 warrants on October 3, raising up to SEK 6.2 million before issue costs. BioStock reached out to CEO Patrik Eschricht for a comment.Read the full interview with Patrik Eschricht at biostock.se: https://www.biostock.se/en/2024/10/phi-accelerates-growth-with-record-order/ This is a press release

AddSecure's sustainability program earns gold rating for third consecutive year

EcoVadis, the world’s leading provider of sustainability ratings, has ranked AddSecure in the top 5% of over 130,000 companies assessed globally.AddSecure  has once again been awarded the prestigious gold rating by EcoVadis , the world’s leading provider of sustainability ratings. This marks the third consecutive year that the European leader in secure IoT connectivity and end-to-end solutions has ranked in the top 5% of over 130,000 companies assessed globally.   EcoVadis methodology is built on international sustainability

Read original

MilDef launches Dismounted Soldier concept suite at AUSA, engineered for excellence in every mission

To empower each individual soldier on the battlefield, MilDef launches its Dismounted Soldier System (DSS) to provide state of the art situational awareness and seamless interoperability across all environments. Experience the concept at the AUSA convention in Washington D.C.MilDef’s suite for dismounted soldiers offers uncompromised durability and performance and is built on a range of hardware and software components that are not only rugged and durable but also highly adaptable to meet specific mission requirements. Whether it’s extreme temperatures, rough terrains, or high-stress combat

Invitation to Alfa Laval’s third quarter conference call

Alfa Laval will release third quarter earnings on 24 October at 07:30 am CET. The conference call will start at 09:00 am CET.The conference call is hosted by Alfa Laval’s President and CEO Tom Erixon and CFO Fredrik Ekström. To participate in the conference call and ask questions, please register here: https://services.choruscall.it/DiamondPassRegistration/register?confirmationNumber=2397096&linkSecurityString=581ebafe0 

Nomination Committee for the Saab Annual General Meeting 2025

The Nomination Committee for Saab AB for the Annual General Meeting 2025 has now been appointed based on the shareholder structure on 31 August 2024.Members of the Saab Nomination Committee are:   · Marcus Wallenberg, Chairman of the Board of Saab AB · Daniel Nodhäll, Investor AB · Peter Wallenberg Jr, Wallenberg Investments AB · Marianne Nilsson, Swedbank Robur Funds · Anna Magnusson, Första AP-fonden  The Nomination Committee is assigned to prepare proposals regarding Chairman of the Annual General Meeting, Board of Directors, Chairman of the Board of Directors,

Dates for SSAB’s financial reports in 2025

Dates for SSAB’s financial reports in 2025 and the AGM. January 29, 2025 Year-end report for 2024 April 29, 2025  Q1 – Interim report for January-March 2025 July 23, 2025  Q2 – Interim report for January-June 2025 October 22, 2025 Q3 – Interim report for January-September 2025 Reports are published at 7.30am CET/CEST on the release date unless otherwise announced. The Annual Report for 2024 will be published during week 12. The Annual General Meeting 2025 will be held on April 29, 2025. For further information, please contact:Investor Relations: Per

Volvo Cars' global sales up 1 per cent in September

Volvo Cars reported global sales of 62,458 cars in September, up 1 per cent compared to the same period last year.  The company's sales of electrified models, fully electric and plug-in hybrid models, grew 43 per cent compared to the same period last year and accounted for 48 per cent of all cars sold during September. The share of fully electric cars constituted 24 per cent of all cars sold for the month. The total sales for the period of January through September amounted to 560,922 cars globally, an increase of 10 per cent compared to the same period 2023.   “The overall market

Mainstream Renewable Power reaches financial close on 50 MW solar PV plant to provide new flexible PPAs to private customers in South Africa

— New PPA product gives businesses a better alternative for their electricity supplyMainstream Renewable Power (“Mainstream”), the pureplay global wind and solar company majority-owned by Aker Horizons ASA, has reached financial close on its 50 MW Ilikwa solar PV plant. The power from the plant will supply multiple private commercial and industrial customers under flexible, shorter-term Power Purchase Agreements (PPAs) in a new-to-market product called Renewable Energy Supply Agreements (“RESAs”).  This new product opens up the energy market in South Africa by giving a wider range of

Qlife starts sales of its PHE rare disease test, addressing an unmet need in the at-home testing market worth SEK 2.5 billion

Resent due to technical problems news distributor. Since its inception, Qlife has been developing the Phenylalanine (PHE) test capsule and is now prepared to offer it for sale to individuals with Phenylketonuria. Initially, the at-home PHE test will be available as a research-use-only (CE-RUO) product, designed to supplement existing testing routines until it receives full regulatory approval. The company plans to begin the process of registering the test as an in-vitro diagnostic (IVD) later this year, starting in the UK and expanding to the EU and other markets.An at-home PHE test will

New Peer-Reviewed Clinical Case Series in the U.S. Shows 100% Diagnostic Accuracy with EndoDrill GI

The cancer diagnostics company BiBBInstruments AB ("BiBB or the "Company"), the developer of the world's first market-cleared electric-driven biopsy instrument for endoscopy, announces that the first eight patient cases using EndoDrill[®] GI in the U.S. have been scientifically published in Endoscopy International Open. Biopsies were sampled in the pancreas, esophagus, stomach, and small intestine. In all cases EndoDrill[® ]GI obtained 100% diagnostic accuracy after only one needle pass. In four patients, both EndoDrill[® ]GI and conventional needles were used to sample the same lesion, in

Industrial pump distributor in the UK has become part of Atlas Copco Group

Nacka, Sweden, October 2, 2024: Kinder-Janes Engineers Ltd (“Kinder-Janes”), an industrial pump distributor headquartered in St. Albans, UK, has become part of Atlas Copco Group.Kinder-Janes was founded in 1957 and has 20 employees. “Through this acquisition we can further expand and penetrate the UK pump market, in line with our strategy to provide even better and closer service to our customers”, said Andrew Walker, Business Area President Power Technique. The purchase price is not disclosed. During 2023 the company had revenues of 12,5 MGBP (164 MSEK*). The company will become

Hygienic pump manufacturer in the Netherlands has become part of Atlas Copco Group

Nacka, Sweden, October 2, 2024: Pomac BV (“Pomac”), a Dutch company which develops and manufactures hygienic pumps, has become part of Atlas Copco Group.Pomac, founded in 1977 and headquartered in Tolbert, develops and manufactures a complete product range of hygienic pumps under the brand name Pomac Pumps. The pumps are used worldwide in various industries, mainly in the food & beverage industry. “Through this acquisition we further expand our product portfolio within the industrial pump market with additional technology and a wide product portfolio”, said Andrew Walker, Business Area

There are no items matching the current filter
There are no more items matching the current filter
Back to top